Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1351083

registered interest
date	18/08/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Influenza: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what criteria his Department will use to determine whether the temporary expansion of eligibility for flu vaccination to people aged over 50 should be made permanent.
tabling member constituency	Halton
tabling member printed	Derek Twigg
uin	40612
answer	answer is ministerial correction date of answer 08/09/2021 answer text <p>Advice from the Joint Committee on Vaccination and Immunisation (JCVI) noted that it was advisable to continue the vaccination of the 50–64-year-old cohort because from the age of 50 years old, individuals are at a greater risk of being hospitalised as a result of COVID-19 and the result of coinfection of COVID-19 and flu is likely to be more severe. However, no decision has been made on whether the eligibility of this cohort will be made permanent.</p><p>The Department will continue to consider the advice of the JCVI in decisions on which flu cohorts are recommended for a flu vaccine in the future. The JCVI use the National Institute for Health and Care Excellence’s methodology and criteria to assess whether a vaccine programme can be considered cost effective or not.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 08/09/2021 15:02:32 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 18931 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	429 label Biography information for Derek Twigg

1349570

registered interest
date	22/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when the Government plans to publish the impact assessment on making covid-19 vaccination a condition of deployment in care homes; and what engagement is planned with the social care sector on that matter.
tabling member constituency	Dulwich and West Norwood
tabling member printed	Helen Hayes
uin	38354
answer	answer is ministerial correction date of answer 08/09/2021 answer text <p>The £100 million estimate set out in the Impact Statement refers to the midpoint of the potential cost of the policy; the number of staff leaving care homes and the impact on employers could be lower than this estimate. Given this uncertainty, we are continuing to monitor the uptake rate and the potential impact of the regulations on the ability of care homes to continue delivering the best quality care.</p><p> </p><p>The Government published operational guidance on 4 August 2021 to support providers to implement the policy. The Guidance provides information on good employment practice for care homes, including on the importance of following a fair procedure before dismissing.</p><p> </p><p>We are working with Skills for Care to ensure that resources such as guidance and best practice are available to support providers and local authorities with capacity and workforce planning, recruitment and well-being.</p><p> </p><p>To support providers with the implementation of the policy, the Advisory, Conciliation and Arbitration Service (ACAS) have published high-level advice on vaccination as a condition of deployment. ACAS are developing more detailed guidance to further support and share good practice across the sector.</p><p> </p><p>The full impact assessment on making COVID-19 vaccination a condition of deployment in care homes will be published as soon as possible.</p><p>The Department has worked closely with stakeholders throughout the development of this policy and will continue to do so throughout its implementation.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 38355 question first answered 08/09/2021 15:10:45 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 18938 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4510 label Biography information for Helen Hayes

1349571

registered interest
date	22/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the Statement of impact – The Health and Social Care Act 2008 (Regulated Activities) (Amendment) (Coronavirus) Regulations 2021 updated 19 July 2021 and the estimated of £100 million for making vaccination a condition of deployment in care homes, how that cost will be funded; and what (a) legal and (b) employment expertise will be made available to care home providers to implement that policy.
tabling member constituency	Dulwich and West Norwood
tabling member printed	Helen Hayes
uin	38355
answer	answer is ministerial correction date of answer 08/09/2021 answer text <p>The £100 million estimate set out in the Impact Statement refers to the midpoint of the potential cost of the policy; the number of staff leaving care homes and the impact on employers could be lower than this estimate. Given this uncertainty, we are continuing to monitor the uptake rate and the potential impact of the regulations on the ability of care homes to continue delivering the best quality care.</p><p> </p><p>The Government published operational guidance on 4 August 2021 to support providers to implement the policy. The Guidance provides information on good employment practice for care homes, including on the importance of following a fair procedure before dismissing.</p><p> </p><p>We are working with Skills for Care to ensure that resources such as guidance and best practice are available to support providers and local authorities with capacity and workforce planning, recruitment and well-being.</p><p> </p><p>To support providers with the implementation of the policy, the Advisory, Conciliation and Arbitration Service (ACAS) have published high-level advice on vaccination as a condition of deployment. ACAS are developing more detailed guidance to further support and share good practice across the sector.</p><p> </p><p>The full impact assessment on making COVID-19 vaccination a condition of deployment in care homes will be published as soon as possible.</p><p>The Department has worked closely with stakeholders throughout the development of this policy and will continue to do so throughout its implementation.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 38354 question first answered 08/09/2021 15:10:45 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 18944 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4510 label Biography information for Helen Hayes

1348636

registered interest
date	20/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment the Government has made of the demographic breakdown of people who have been hospitalised with covid-19 after receiving (a) one and (b) two doses of a vaccine.
tabling member constituency	Birmingham, Edgbaston
tabling member printed	Preet Kaur Gill
uin	36724
answer	answer is ministerial correction date of answer 15/09/2021 answer text <p>Public Health England publishes the age and sex breakdown of hospitalisations for COVID-19 for the most recent four week period on a weekly basis at the following link:</p><p><a href="https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fstatistics%2Fnational-flu-and-covid-19-surveillance-reports-2021-to-2022-season&amp;data=04%7C01%7Ccovid19surv%40phe.gov.uk%7Cd8a5d4ca5e2f4eec8d8208d94c3161e0%7Cee4e14994a354b2ead475f3cf9de8666%7C0%7C0%7C637624597245146774%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=BkHeLCF%2BjpJrbhFP464Z7rzY3nC%2BJubS5l4XJFMrOK8%3D&amp;reserved=0" target="_blank">https://www.gov.uk/government/statistics/national-flu-and-covid-19-surveillance-reports-2021-to-2022-season</a></p><p>The analysis is based on data from a sentinel network of acute National Health Service trusts contributing enhanced data.</p><p>PHE publishes technical briefings which provide the latest data regarding hospitalisations and deaths by variant, including the Delta variant, as well as data concerning those hospitalised with the Delta variant of COVID-19 who are vaccinated with one and both doses and unvaccinated. These data are retrospective and do not represent current hospitalisations. Data is available from 1 February 2021 at the following link:</p><p><a href="https://www.gov.uk/government/publications/investigation-of-novel-sars-cov-2-variant-variant-of-concern-20201201" target="_blank">https://www.gov.uk/government/publications/investigation-of-novel-sars-cov-2-variant-variant-of-concern-20201201</a></p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 15/09/2021 15:51:12 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 18922 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4603 label Biography information for Preet Kaur Gill

1348754

registered interest
date	20/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether it is his policy to ensure that in any booster vaccine programme third doses of covid-19 vaccines are prioritised for people who are immunosuppressed in (a) Newcastle upon Tyne and (b) other areas with a number of cases.
tabling member constituency	Newcastle upon Tyne East
tabling member printed	Mr Nicholas Brown
uin	36530
answer	answer is ministerial correction date of answer 13/09/2021 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) recognises that some individuals who are severely immunosuppressed due to underlying health conditions or medical treatment may not achieve the same full immune response to the initial two dose COVID-19 vaccination course as those who are not immunosuppressed. The committee has therefore advised on 1 September that as a precautionary measure those with severe immunosuppression at or around the time of their first or second dose of COVID-19 vaccination should receive a third dose. The aim is to raise the level of immunity in these individuals closer to the level of immunity as the non-immunosuppressed achieve from two doses in Newcastle upon Tyne and other areas.</p><p>The Government has accepted this advice, which will be applied at a national level. Severe immunosuppression at the time of vaccination is defined using guidance and timings outlined at the following link:</p><p><a href="https://www.gov.uk/government/publications/third-primary-covid-19-vaccine-dose-for-people-who-are-immunosuppressed-jcvi-advice/joint-committee-on-vaccination-and-immunisation-jcvi-advice-on-third-primary-dose-vaccination" target="_blank">https://www.gov.uk/government/publications/third-primary-covid-19-vaccine-dose-for-people-who-are-immunosuppressed-jcvi-advice/joint-committee-on-vaccination-and-immunisation-jcvi-advice-on-third-primary-dose-vaccination</a></p><p>The purpose of the separate potential booster programme is to maximise protection in those who are most vulnerable to serious COVID-19 ahead of the winter months. The JCVI published interim advice on a potential Covid-19 booster vaccination programme on 30 June 2021, which is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022/jcvi-interim-advice-potential-covid-19-booster-vaccine-programme-winter-2021-to-2022" target="_blank">https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022/jcvi-interim-advice-potential-covid-19-booster-vaccine-programme-winter-2021-to-2022</a></p><p>Final decisions on the timing and scope and cohort eligibility of any COVID-19 vaccine booster programme will be confirmed once the JCVI has provided their final advice.</p><p>It is expected that severely immunosuppressed individuals will become eligible for a booster dose as part of any routine booster programme from around six months after their third dose, pending further advice.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 13/09/2021 16:33:45 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 18935 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	523 label Biography information for Mr Nicholas Brown

1348100

registered interest
date	19/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support the health and wellbeing needs of people who are currently participating in trials of unapproved covid-19 vaccines.
tabling member constituency	Brent Central
tabling member printed	Dawn Butler
uin	35555
answer	answer is ministerial correction date of answer 28/07/2021 answer text <p>Participants in all clinical trials are provided with contact details at the local site should they have any health and wellbeing concerns which may be related to the trial.</p><p>The trial’s principle investigator advise the participant based on their knowledge of whether the participant received an active COVID-19 vaccine trial product or a placebo.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 28/07/2021 13:36:04 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 16515 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1489 label Biography information for Dawn Butler

1348444

registered interest
date	19/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus Certificates: EU Countries
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help ensure that there is mutual recognition of EU covid-19 vaccine records.
tabling member constituency	Hornsey and Wood Green
tabling member printed	Catherine West
uin	35821
answer	answer is ministerial correction date of answer 25/08/2021 answer text <p>As part of the commitment to ensure the safe return to international travel, the Government continues to engage with the European Commission and other International Partnerships on certification to ensure that travel between the United Kingdom (UK) and other nations is unhindered and supported by a common approach. The UK and European Union (EU) are aligned in the technical approach to COVID-19 status certification, with the UK supporting global consistent minimum technical standards in an interoperable and cross-border way. We are making effective use of our chair of the G7 meeting in 2021 to ensure G7 nations made a commitment that clinical trial participants will not be disadvantaged in certification processes.</p><p>Passengers from amber countries who have been fully vaccinated with vaccines authorised by the European Medicines Agency, in the U.S. Food and Drug Administration or in the Swiss vaccination programme, will be able to travel to England without quarantine, or a day eight test.</p><p>The EU has published a list of vaccines to be accepted by EU member countries which can be found at the following link:</p><p><a href="https://reopen.europa.eu/en" target="_blank">https://reopen.europa.eu/en</a></p><p>Based on the list and related documentation, all UK vaccines would be recognised by the EU and European Economic Area countries for the purposes of waiving travel restrictions.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 25/08/2021 14:31:18 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 16524 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4523 label Biography information for Catherine West

1347742

registered interest
date	16/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much (a) his Department and (b) the NHS has spent on (i) advertising using social media and other forms of information channels and (ii) other public information to encourage people to uptake the covid-19 vaccine to date; and how much has been spent on public information to encourage minority communities to receive that vaccination.
tabling member constituency	Reading East
tabling member printed	Matt Rodda
uin	34567
answer	answer is ministerial correction date of answer 26/07/2021 answer text <p>The Department spent £1.3 million on advertising between December 2020 and 31 January 2021. Activity included tailored content designed to specifically support multicultural communities. Some local National Health Service teams ran COVID-19 vaccine campaigns, but this information is not collected centrally.</p><p>Campaign spending supporting the COVID-19 vaccination programme transferred to the Cabinet Office in February 2021.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 26/07/2021 12:30:17 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 16047 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4654 label Biography information for Matt Rodda

1347815

registered interest
date	16/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pregnancy: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the process is for ensuring health professionals (a) are discussing with pregnant women the risks and benefits of the covid-19 vaccine and (b) have up to date information on the risks and benefits of the vaccine.
tabling member constituency	Battersea
tabling member printed	Marsha De Cordova
uin	34580
answer	answer is ministerial correction date of answer 13/08/2021 answer text <p>NHS England and NHS Improvement are working with regional teams and providers to ensure that advice on vaccination in pregnancy, including the risks and benefits of vaccination to pregnant women, is being offered antenatally and that information materials are available across antenatal and primary care settings. To ensure that healthcare professionals are having these discussions, NHS England and NHS Improvement have asked maternity and primary care services to support all general practitioners, practice nurses, midwives and obstetricians to give objective, evidence-based advice to women on vaccination in pregnancy at every antenatal contact. For healthcare professionals, there is also a checklist to aid discussions on the potential benefits and risks of COVID-19 vaccination in pregnancy, and to gain informed consent. This is available at the following link:</p><p><a href="https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2021/04/C1293-COVID-19-vaccination-in-pregnancy-vaccinator-checklist-version-2-19-May-2021.pdf" target="_blank">https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2021/04/C1293-COVID-19-vaccination-in-pregnancy-vaccinator-checklist-version-2-19-May-2021.pdf</a></p><p>As part of their professional development, healthcare professionals and medical staff are expected to familiarise themselves with the latest guidance on matters of clinical importance. This could be through a range of mediums including clinical guidance from the National Institute for Health and Care Excellence, journal reviews, circulars, bulletins, Royal Colleges guidance, information from the General Medical Council and guidance from Public Health England.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 13/08/2021 14:54:32 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 16060 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4676 label Biography information for Marsha De Cordova

1346801

registered interest
date	14/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Travel: Malta
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions his Department is having with its counterpart in Malta in respect of British tourists' entry to Malta whose covid-19 vaccine was manufactured at Serum Institute in India.
tabling member constituency	North Tyneside
tabling member printed	Mary Glindon
uin	33225
answer	answer is ministerial correction date of answer 22/07/2021 answer text <p>Following discussions with the Government of Malta, they are now accepting all travellers vaccinated with vaccine batch releases approved by the Medicines and Healthcare products Regulatory Agency. This includes accepting all those who have received the AstraZeneca vaccine manufactured in the Serum Institute of India under the United Kingdom’s vaccination programme.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 22/07/2021 14:31:22 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 15312 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4126 label Biography information for Mary Glindon